Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06095050

Embolization Treatment of Chronic Refractory Shoulder Tendinopathy

Efficacy of Lipiodol Embolization for Chronic Tendinopathy of the Rotator Cuff

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
41 (estimated)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a randomized controlled trial in which patients with moderate to severe shoulder pain (Visual Analog Scale (VAS) \> 40), in the setting of rotator cuff tendinopathy refractory to conservative treatment, will be enrolled. The primary aim of the study is to estimate the effect of transcatheter arterial embolization (TAE) with physical therapy (PT) vs PT alone on the change in shoulder pain at 12-month follow up. Scientific objectives also include an assessment of safety of the intervention, assessment of changes in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity score, Shoulder Pain and Disability Index (SPADI) scores, MRI Tendinopathy Score between the TAE + PT and PT groups.

Detailed description

This is a single center prospective randomized controlled study at Brigham \& Women's Hospital (BWH), a teaching hospital of Harvard Medical School. Patients with clinical and MRI findings of shoulder tendinopathy, moderate to severe shoulder pain (VAS \> 40), and pain refractory to at least 6 months of physician directed conservative therapy will be eligible for enrollment.At screening patient will undergo a shoulder MRI to evaluate for tendinopathy, and patients with complete full thickness tendon tears will be excluded. Patients will be randomized to either the TAE +PT or PT group. Patients in the TAE + PT group will undergo angiography to evaluate branch shoulder arteries for hyperemia. If hyperemia is present, then embolization will be performed. This treatment will be followed by 3 months of structured PT. Patients in the PT group will undergo 3-months of structured physical therapy with isolated eccentric exercises.

Conditions

Interventions

TypeNameDescription
DEVICEEmbolizationSuperselective arterial embolization of hyperemic vasculature in the symptomatic shoulder (utilizing the IDE approved device: Lipiodol) followed by structured physical therapy sessions.
OTHERPhysical TherapySubjects will participate in structured physical therapy consisting of 3 months of eccentric strength training. This twelve-week program will consist of 4 PT sessions at week 0, week 4, week 8, and week 12.

Timeline

Start date
2025-01-16
Primary completion
2027-01-16
Completion
2028-04-21
First posted
2023-10-23
Last updated
2026-02-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06095050. Inclusion in this directory is not an endorsement.